• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Dasatinib

Pharmacogenomic Information
  

 Drug Link
in Drugs@FDA
Therapeutic AreaHUGO
Symbol
Referenced
Subgroup
Labeling Sections with
Pharmacogenomic
Information
DasatinibOncologyBCR/ABL1Philadelphia chromosome
(t(9;22)) positive; T315I mutation-positive
Indications and Usage
Clinical Studies
Patient Counseling Information

 

back to Table of Pharmacogenomic Biomarkers in Drug Labeling